Diane Weiser | VP of Corporate Communications & IR |
Andrew Wolff | Senior VP & Chief Medical Officer |
Robert Blum | President, CEO & Director |
Peter Roddy | Senior VP & CAO |
Fady Malik | EVP of Research & Development |
Ching Jaw | SVP and Chief Financial Officer |
Joe Pantginis | H.C. Wainwright |
Matthew Harrison | Morgan Stanley |
Mara Goldstein | Cantor Fitzgerald |
Jason Butler | JMP Securities |
Chad Messer | Needham & Company |
Vernon Bernardino | Seaport Global |
Good afternoon and welcome, ladies and gentlemen, to the Cytokinetics' Third Quarter 2017 Conference Call. [Operator Instructions] I will now turn the call over to Diane Weiser, Cytokinetics' Vice President of Corporate Communications and Investor relations. Please go ahead.
Good afternoon, everyone and thanks for joining us today. On today’s call we’ll be trying a new format which we hope it’ll be more informative for you, instead of primarily recapping accomplishments achieved during the past quarter for which we have already press releases.